[go: up one dir, main page]

NO20091624L - Fremgangsmate for fremstilling av en krystallinsk pyrazolo[1,5-A]pyrimidinforbindelse - Google Patents

Fremgangsmate for fremstilling av en krystallinsk pyrazolo[1,5-A]pyrimidinforbindelse

Info

Publication number
NO20091624L
NO20091624L NO20091624A NO20091624A NO20091624L NO 20091624 L NO20091624 L NO 20091624L NO 20091624 A NO20091624 A NO 20091624A NO 20091624 A NO20091624 A NO 20091624A NO 20091624 L NO20091624 L NO 20091624L
Authority
NO
Norway
Prior art keywords
pyrazolo
preparation
crystalline
pyrimidine compound
pyrimidine
Prior art date
Application number
NO20091624A
Other languages
English (en)
Other versions
NO342009B1 (no
Inventor
Antonio Guglietta
Luis Anglada
Albert Palomer
Original Assignee
Ferrer Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferrer Int filed Critical Ferrer Int
Publication of NO20091624L publication Critical patent/NO20091624L/no
Publication of NO342009B1 publication Critical patent/NO342009B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives en ny fremgangsmåte for industriell fremstilling av polymorf B av N-{2-Fluor-5-[3-(tiofen-2-karbonyl)-pyrazolo[l,5-a] pyrimidin-7-yl-fenyl}-N-metylacetamid.
NO20091624A 2006-10-11 2009-04-23 Fremgangsmåte for fremstilling av en krystallinsk pyrazolo[1,5-a]pyrimidin forbindelse NO342009B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85101106P 2006-10-11 2006-10-11
EP06122143A EP1956021A1 (en) 2006-10-11 2006-10-11 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound
PCT/EP2007/060796 WO2008043799A1 (en) 2006-10-11 2007-10-10 Process for the manufacture of a crystalline pyrazolo[1,5-a]pyrimidine compound

Publications (2)

Publication Number Publication Date
NO20091624L true NO20091624L (no) 2009-05-07
NO342009B1 NO342009B1 (no) 2018-03-12

Family

ID=37808282

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091624A NO342009B1 (no) 2006-10-11 2009-04-23 Fremgangsmåte for fremstilling av en krystallinsk pyrazolo[1,5-a]pyrimidin forbindelse

Country Status (23)

Country Link
US (1) US8008486B2 (no)
EP (2) EP1956021A1 (no)
JP (1) JP5270555B2 (no)
KR (1) KR101409573B1 (no)
CN (1) CN101573362B (no)
AR (1) AR065831A1 (no)
AT (1) ATE503758T1 (no)
AU (1) AU2007306318B2 (no)
BR (1) BRPI0717836A2 (no)
CA (1) CA2664900C (no)
CL (1) CL2007002929A1 (no)
DE (1) DE602007013596D1 (no)
DK (1) DK2081934T3 (no)
ES (1) ES2362631T3 (no)
MX (1) MX2009003567A (no)
NO (1) NO342009B1 (no)
PL (1) PL2081934T3 (no)
PT (1) PT2081934E (no)
RU (1) RU2404984C1 (no)
SI (1) SI2081934T1 (no)
TW (1) TWI425000B (no)
UY (1) UY30619A1 (no)
WO (1) WO2008043799A1 (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1884516A1 (en) * 2006-08-04 2008-02-06 Ferrer Internacional, S.A. Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399621B1 (en) * 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
EP1477169A1 (en) * 1999-09-02 2004-11-17 Neurocrine Biosciences, Inc. Reactions of polymorphs of N-methyl-N-(3-(3-(2-thienylcarbonyl)-pyrazol-(1,5-alpha)-pyrimidin-7-yl)phenyl)acetamide
AU8311901A (en) * 2000-08-03 2002-02-18 American Home Prod Polymorphs of zaleplon and methods for the preparation thereof
MXPA05002251A (es) * 2002-08-26 2005-06-08 Neurocrine Biosciences Inc Polimorfo novedoso del n- metil -n- (3- {3-[2- tienilcarbonil] -pirazol -[1, 5-(alfa)] -pirimidina- 7-yl} fenil) acetamida y composiciones y metodos relacionados.
ES2222813B1 (es) 2003-07-24 2005-12-16 Ferrer Internacional, S.A. N-(3-(3-sustituidas-pirazolo(1,5-a)pirimidin-7-il)-fenil)-sulfonamidas y composiciones y metodos relacionados.
US20060064488A1 (en) * 2004-09-17 2006-03-23 Ebert Robert F Electronic software distribution method and system using a digital rights management method based on hardware identification
EP1736475A1 (en) * 2005-06-21 2006-12-27 Ferrer Internacional, S.A. Halogenated pyrazolo[1,5-a]pyrimidines, processes, uses, compositions and intermediates

Also Published As

Publication number Publication date
KR20090077806A (ko) 2009-07-15
ES2362631T3 (es) 2011-07-08
AU2007306318A1 (en) 2008-04-17
HK1134924A1 (en) 2010-05-20
BRPI0717836A2 (pt) 2014-05-20
AU2007306318B2 (en) 2012-07-05
PL2081934T3 (pl) 2011-08-31
NO342009B1 (no) 2018-03-12
EP2081934B1 (en) 2011-03-30
PT2081934E (pt) 2011-06-29
AR065831A1 (es) 2009-07-08
EP2081934A1 (en) 2009-07-29
CA2664900C (en) 2015-07-07
DE602007013596D1 (de) 2011-05-12
JP2010505913A (ja) 2010-02-25
RU2404984C1 (ru) 2010-11-27
CN101573362A (zh) 2009-11-04
WO2008043799A1 (en) 2008-04-17
US8008486B2 (en) 2011-08-30
KR101409573B1 (ko) 2014-06-19
HK1130250A1 (en) 2009-12-24
TW200825085A (en) 2008-06-16
CA2664900A1 (en) 2008-04-17
UY30619A1 (es) 2008-03-31
DK2081934T3 (da) 2011-07-11
EP1956021A1 (en) 2008-08-13
SI2081934T1 (sl) 2011-07-29
CN101573362B (zh) 2012-06-27
MX2009003567A (es) 2009-04-14
JP5270555B2 (ja) 2013-08-21
US20100048896A1 (en) 2010-02-25
CL2007002929A1 (es) 2008-05-16
TWI425000B (zh) 2014-02-01
ATE503758T1 (de) 2011-04-15

Similar Documents

Publication Publication Date Title
MY152283A (en) Polo-like kinase inhibitirs
WO2007023382A3 (en) Pyrimidine amino pyrazole compounds, potent kinase inhibitors
WO2006121528A3 (en) Ring closing and related methods and intermediates
TW200745121A (en) Chemical compound
WO2008003958A3 (en) Fused pyrimido compounds
WO2009146034A3 (en) Mapk/erk kinase inhibitors and methods of use thereof
EA201170771A1 (ru) Органические соединения
NO20084783L (no) Syntese av acylaminoalkenylenamider nyttige som substans P antagonister
EA201000883A1 (ru) Производные индолинона и способ их получения
NO20065321L (no) Fremgangsmate for fremstilling av clopidogrelhydrogensulfat polymorf for I
WO2004072030A3 (en) Process for preparing pyrrolotriazine kinase inhibitors
WO2006041831A3 (en) Cyclic β-amino acid derivatives as factor xa inhibitors
IL174469A0 (en) Rearranged pentanols, a method for the production thereof, and their use as antiphlogistics
WO2007045420A3 (en) 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors
WO2009129401A8 (en) Kinase inhibitors
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
WO2007104485A3 (de) Substituierte imidazo[2,1-b]thiazol-verbindungen und ihre verwendung zur herstellung von arzneimitteln
WO2008045834A3 (en) Kinase inhibitors
WO2007057225A3 (en) Process for making montelukast and intermediates therefor
EA200600563A1 (ru) Способ получения рензаприда и его промежуточных соединений
WO2008054796A3 (en) Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
NO20091624L (no) Fremgangsmate for fremstilling av en krystallinsk pyrazolo[1,5-A]pyrimidinforbindelse
NO20072551L (no) Fremgangsmate for fremstilling av purinforbindelser
WO2008054795A3 (en) Triazolopyrimidine derivatives as adp p2y12 receptor antagonists
WO2007096903A3 (en) New crystalline form of atorvastatin hemi-calcium

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees